Geoffrey S. Dow - 09 Jun 2025 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role: President and CEO, Director
Signature: /s/ Geoffrey Dow
Issuer symbol: SXTP
Transactions as of: 09 Jun 2025
Net transactions value: +$13,065
Form type: 4
Filing time: 09 Jun 2025, 17:23:56 UTC
Previous filing: 21 Jan 2025
Next filing: 15 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
DOW GEOFFREY S	President and CEO, Director	C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON	/s/ Geoffrey Dow	09 Jun 2025	0001977231

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SXTP	Common Stock	Award	$13,065	+4,376	+20%	$2.99	26,171	09 Jun 2025	Direct	F2
holding	SXTP	Common Stock						11,119	09 Jun 2025	By Geoffrey S. Dow Revocable Trust	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Dow is the trustee of the Geoffrey S. Dow Revocable Trust, of which he is the trustee and has voting and dispositive control.
F2	Reflects a 1-for-5 reverse stock split effective February 24, 2025. As a result, the reporting person's direct beneficial ownership was adjusted from 108,974 shares to 21,795 shares, and indirect beneficial ownership was adjusted from 55,596 shares to 11,119 shares. Fractional shares resulting from the split were rounded up to the nearest whole share.